Publications by authors named "Juan Ignacio Lopez-Carbonero"
Article Synopsis
- The study evaluated five cognitive screening tests to diagnose mild cognitive impairment (MCI) in 140 participants experiencing memory loss, with an average age of around 74.5 years.
- Results showed that the Addenbrooke's Cognitive Examination III (ACE-III) and its short version Mini-Addenbrooke (M-ACE) had the best diagnostic accuracy for MCI, outperforming tests like the Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE).
- The M-ACE, in particular, balanced strong diagnostic performance with a quicker administration time, while tests like the Memory Impairment Screen (MIS) and Rowland Universal Dementia Assessment Scale (RUDAS) had limited
Post-COVID condition (PCC) and multiple sclerosis (MS) share some clinical and demographic features, including cognitive symptoms and fatigue. Some pathophysiological mechanisms well-known in MS, such as autoimmunity, neuroinflammation and myelin damage, have also been implicated in PCC. In this study, we aimed to compare the cognitive phenotypes of two large cohorts of patients with PCC and MS, and to evaluate the relationship between fatigue and cognitive performance.
View Article and Find Full Text PDFIntroduction: The Addenbrooke's Cognitive Examination III (ACE-III) is a brief test useful for neuropsychological assessment. Several studies have validated the test for the diagnosis of Alzheimer's disease (AD) and frontotemporal dementia (FTD). In this study, we aimed to examine the metabolic correlates associated with the performance of ACE-III in AD and behavioral variant FTD.
View Article and Find Full Text PDF